These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 17133484)

  • 21. Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer.
    Myers R; Greiner S; Harvey M; Soeffker D; Frenzke M; Abraham K; Shaw A; Rozenblatt S; Federspiel MJ; Russell SJ; Peng KW
    Cancer Gene Ther; 2005 Jul; 12(7):593-9. PubMed ID: 15746945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses.
    Zimmermann M; Armeanu S; Smirnow I; Kupka S; Wagner S; Wehrmann M; Rots MG; Groothuis GM; Weiss TS; Königsrainer A; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2009 May; 34(5):1247-56. PubMed ID: 19360338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.
    Dingli D; Peng KW; Harvey ME; Greipp PR; O'Connor MK; Cattaneo R; Morris JC; Russell SJ
    Blood; 2004 Mar; 103(5):1641-6. PubMed ID: 14604966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic measles virus targets high CD46 expression on multiple myeloma cells.
    Ong HT; Timm MM; Greipp PR; Witzig TE; Dispenzieri A; Russell SJ; Peng KW
    Exp Hematol; 2006 Jun; 34(6):713-20. PubMed ID: 16728275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
    Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
    Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer.
    Argnani R; Marconi P; Volpi I; Bolanos E; Carro E; Ried C; Santamaria E; Pourchet A; Epstein AL; Brocker T; Corrales FJ; Manservigi R; Goicoechea I; Foschini M; Hernandez-Alcoceba R
    Liver Int; 2011 Nov; 31(10):1542-53. PubMed ID: 22093330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expression.
    Grote D; Cattaneo R; Fielding AK
    Cancer Res; 2003 Oct; 63(19):6463-8. PubMed ID: 14559838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity.
    Allen C; Vongpunsawad S; Nakamura T; James CD; Schroeder M; Cattaneo R; Giannini C; Krempski J; Peng KW; Goble JM; Uhm JH; Russell SJ; Galanis E
    Cancer Res; 2006 Dec; 66(24):11840-50. PubMed ID: 17178881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
    Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
    Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy.
    Xia M; Luo D; Dong J; Zheng M; Meng G; Wu J; Wei J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):408. PubMed ID: 31533779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
    Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
    Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats.
    Ebert O; Shinozaki K; Huang TG; Savontaus MJ; García-Sastre A; Woo SL
    Cancer Res; 2003 Jul; 63(13):3605-11. PubMed ID: 12839948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.
    Galanis E; Atherton PJ; Maurer MJ; Knutson KL; Dowdy SC; Cliby WA; Haluska P; Long HJ; Oberg A; Aderca I; Block MS; Bakkum-Gamez J; Federspiel MJ; Russell SJ; Kalli KR; Keeney G; Peng KW; Hartmann LC
    Cancer Res; 2015 Jan; 75(1):22-30. PubMed ID: 25398436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma.
    Domingo-Musibay E; Allen C; Kurokawa C; Hardcastle JJ; Aderca I; Msaouel P; Bansal A; Jiang H; DeGrado TR; Galanis E
    Cancer Gene Ther; 2014 Nov; 21(11):483-90. PubMed ID: 25394505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression.
    Hallak LK; Merchan JR; Storgard CM; Loftus JC; Russell SJ
    Cancer Res; 2005 Jun; 65(12):5292-300. PubMed ID: 15958576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.
    Springfeld C; von Messling V; Frenzke M; Ungerechts G; Buchholz CJ; Cattaneo R
    Cancer Res; 2006 Aug; 66(15):7694-700. PubMed ID: 16885371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.
    Lampe J; Bossow S; Weiland T; Smirnow I; Lehmann R; Neubert W; Bitzer M; Lauer UM
    Gene Ther; 2013 Nov; 20(11):1033-41. PubMed ID: 23719065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.